Super potent topical corticosteroid use associated with adrenal suppression: Clinical considerations

Journal of the American Academy of Dermatology

Volumn 38, Issue 2 II, 1998, Pages 318-321

  Gilbertson, E O ^a   Spellman, M C ^a   Piacquadio, D J ^a   Mulford, M I ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; PREDNISONE;

ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; FEMALE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSORIASIS; TOPICAL DRUG ADMINISTRATION;

EID: 0031953032     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(98)70573-0     Document Type: Article

References (27)

1. RC Cornell RB Stoughton Use of glucocorticoids in psoriasis Pharmacol Ther 11 1980 497 508
2. SE Prawer HI Katz Guidelines for using superpotent topical steroids Am Fam Physician 41 1990 1531 1538
3. RB Stoughton RC Cornell Corticosteroids 4th ed TB Fitzpatrick AZ Eisen K Wolff Dermatology in general medicine 1993 McGraw-Hill New York (NY) 2846 2850
4. A Thalen R Brattsand PH Andersson Development of glucocorticosteroids with enhanced ratio between topical and systemic effects Acta Derm Venereol 69 1989 11 19
5. RSC Barneston AD White The use of corticosteroids in dermatological practice Med J Aust 156 1992 428 431
6. F Lawlor K Ramabala Iatrogenic Cushing’s syndrome: a cautionary tale Clin Exp Dermatol 9 1984 286 289
7. K Takeda S Arase F Takahashi Side effects of topical corticosteroids and their prevention Drugs 36 1988 15 23
8. GE Pierard C Pierard-Franchimont T Ben Mosbah Adverse effects of topical corticosteroids Acta Derm Venereol 69 1989 26 30
9. AL Lauerma S Reitamo Contact allergy to corticosteroids J Am Acad Dermatol 28 1993 618 622
10. VP Werth Glucocorticoids in dermatology Curr Opin Dermatol 1993 195 199
11. JA Carruthers PJ August RCD Staughton Observations on the systemic effect of topical clobetasol propionate (Dermovate) BMJ 2 1975 203 204
12. L Patel PE Clayton GM Addison Adrenal function following topical steroid treatment in children with atopic dermatitis Br J Dermatol 132 1995 950 955
13. RCD Staughton PJ August Cushing’s syndrome and pituitary-adrenal suppression due to clobetasol propionate BMJ 2 1975 419 421
14. EM Ohman S Rogers FD Meenan Adrenal suppression following low-dose topical clobetasol propionate J R Soc Med 80 1987 422 424
15. EA Olsen RC Cornell Topical clobetasol 17 propionate: review of its clinical efficacy and safety J Am Acad Dermatol 15 1986 246 255
16. AW Nathan GL Rose Fatal iatrogenic Cushing’s syndrome Lancet 1 1979 207
17. MIB Sneddon Les effets nocifs des steroides en application locale Journee Franco-Britannique de Dermatologie 77 1970 670 672
18. B Gianotti Current treatment guidelines for topical corticosteroids Drugs 36 1988 9 14
19. HI Katz NT Hien SE Prawer Superpotent topical steroid treatment of psoriasis vulgaris: clinical efficacy and adrenal function J Am Acad Dermatol 16 1987 804 811
20. C Thornfeldt RC Cornell RB Stoughton The effect of alclometasone dipropionate cream 0.05% on the hypothalamic-pituitary-adrenal axis of normal volunteers J Int Med Res 13 1985 276 280
21. MH Gold AK Holy HH Roegnik Jr Beta-blocking drugs and psoriasis: a review of cutaneous side effects and retrospective analysis of their effects on psoriasis J Am Acad Dermatol 5 1988 837 841
22. L Gip A Hamfelt Studies of the efficacy and adrenal effects of Diprolene ointment 0.05 percent and Dermovate ointment 0.05 percent in patients with psoriasis and other resistant dermatoses Cutis 33 1984 215 222
23. CA Young IR Williams IA MacFarlane Unrecognized Cushing’s syndrome and adrenal suppression due to topical clobetasol propionate Br J Clin Pract 45 1991 61 62
24. DL Loriaux Tests of adrenal function 2nd ed KL Becker Principles and practice of endocrinology and metabolism 1995 JB Lippincott Co Philadelphia (PA) 662 667
25. NV Esteban T Loughlin AL Yergey Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry J Clin Endocrinol Metab 72 1991 39 45
26. P Walsh JL Aeling L Huff Hypothalamus- pituitary-adrenal axis suppression by superpotent topical steroids J Am Acad Dermatol 29 1993 501 503
27. Physician’s Desk Reference 49th ed 1995 Medical Economics Company Montvale (NJ) 932 933 1010-1,1735,2247-8,2629-30